These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6880726)

  • 1. Adverse effects from the circadian fluctuations of carbamazepine plasma levels.
    Blennow G
    Acta Paediatr Scand; 1983 May; 72(3):397-401. PubMed ID: 6880726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diurnal fluctuations in plasma carbamazepine level in children with epilepsy].
    Losiowski Z; Prokopczyk J; Zimak J; Bielicka J
    Neurol Neurochir Pol; 1988; 22(3):195-200. PubMed ID: 3221956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects.
    Riva R; Albani F; Ambrosetto G; Contin M; Cortelli P; Perucca E; Baruzzi A
    Epilepsia; 1984 Aug; 25(4):476-81. PubMed ID: 6540170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation of carbamazepine and carbamazepine-10,11-epoxide in plasma and saliva in children with epilepsy: a comparison between conventional and slow-release formulations.
    Eeg-Olofsson O; Nilsson HL; Tonnby B; Arvidsson J; Grahn PA; Gylje H; Larsson C; Norén L
    J Child Neurol; 1990 Apr; 5(2):159-65. PubMed ID: 2111837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of individual pharmacokinetic data for treatment of epilepsy with carbamazepine.
    Diehl LW; Müller-Oerlinghausen B; Riedel E
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):144-8. PubMed ID: 1002351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian carbamazepine toxicity.
    Haefeli WE; Meyer PG; Lüscher TF
    Epilepsia; 1994; 35(2):400-2. PubMed ID: 8156964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbamazepine dosage and its blood serum level in children].
    Czochańska J; Losiowski Z; Prokopczyk J; Zimak J
    Neurol Neurochir Pol; 1987; 21(1):6-10. PubMed ID: 3614524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine (CBZ) controlled release compared with conventional CBZ: a controlled study of attention and vigilance in children with epilepsy.
    Pieters MS; Jennekens-Schinkel A; Stijnen T; Edelbroek PM; Brouwer OF; Liauw L; Heyer A; Lanser JB; Peters AC
    Epilepsia; 1992; 33(6):1137-44. PubMed ID: 1464276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects.
    Höppener RJ; Kuyer A; Meijer JW; Hulsman J
    Epilepsia; 1980 Aug; 21(4):341-50. PubMed ID: 7398602
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome].
    Kholodov LE; Prityko AG; Ivanova ES; Sokolov AV; Tishchenkova IF; Dubrovina LIu; Postnikov SS; Tatarinov PA; Kopanev IuA; Veselov NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(3):35-40. PubMed ID: 7571921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects.
    Tomson T
    Arch Neurol; 1984 Aug; 41(8):830-4. PubMed ID: 6466158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow release carbamazepine in treatment of poorly controlled seizures.
    Ryan SW; Forsythe I; Hartley R; Haworth M; Bowmer CJ
    Arch Dis Child; 1990 Sep; 65(9):930-5. PubMed ID: 2221963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children.
    Paxton JW; Aman MG; Werry JS
    Epilepsia; 1983 Dec; 24(6):716-24. PubMed ID: 6641647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy.
    Schoeman JF; Elyas AA; Brett EM; Lascelles PT
    Dev Med Child Neurol; 1984 Dec; 26(6):756-64. PubMed ID: 6440825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbamazepine plasma concentration. Relationship to cognitive impairment.
    O'Dougherty M; Wright FS; Cox S; Walson P
    Arch Neurol; 1987 Aug; 44(8):863-7. PubMed ID: 3632397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent complete atrioventricular block after long term low-dose carbamazepine therapy with a serum concentration less than the therapeutic level.
    Ide A; Kamijo Y
    Intern Med; 2007; 46(9):627-9. PubMed ID: 17473503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The auto-induction of carbamazepine during long-term therapy.
    Pynnönen S; Frey H; Sillanpää M
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):247-52. PubMed ID: 7450925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy.
    Battino D; Bossi L; Croci D; Franceschetti S; Gomeni C; Moise A; Vitali A
    Ther Drug Monit; 1980; 2(4):315-22. PubMed ID: 7222185
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing plasma carbamazepine concentrations.
    Lander CM; Eadie MJ; Tyrer JH
    Clin Exp Neurol; 1977; 14():184-93. PubMed ID: 616596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.